Company Filing History:
Years Active: 2020-2023
Title: Catherine Elliott: Innovator in Microbial Inhibition
Introduction
Catherine Elliott is a prominent inventor based in Brighton, GB. She has made significant contributions to the field of microbial inhibition, particularly through her innovative patents. With a total of 2 patents, her work focuses on developing compounds that can effectively inhibit microbial alternative oxidase and cytochrome bc1 complex.
Latest Patents
Catherine's latest patents include compounds designed for use as inhibitors of alternative oxidase or cytochrome bc1 complex. These inventions provide valuable solutions for inhibiting microbial alternative oxidase (AOX) and/or cytochrome bc1 complex. The applications of these inhibitors extend to agrochemicals and pharmaceuticals, specifically for treating microbial infections, including fungal infections.
Career Highlights
Throughout her career, Catherine has worked with esteemed organizations such as the University of Sussex and Alternox Scientific Limited. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Catherine has collaborated with notable individuals in her field, including Anthony Lennox Moore and Mary Susan Albury. These partnerships have further enriched her work and expanded her impact on microbial research.
Conclusion
Catherine Elliott stands out as an innovative inventor whose work in microbial inhibition has the potential to make significant advancements in both agriculture and medicine. Her contributions continue to inspire future research and development in this vital area.